Vellmine Pharmaceutical Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.50 M
- Company Age 8 Year, 30 Days
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 5.00 M
- Satisfied Charges ₹ 3.00 M
- Revenue Growth 35.93%
- Profit Growth -55.14%
- Ebitda -160.66%
- Total Assets 52.26%
About Vellmine Pharmaceutical Llp
Vellmine Pharmaceutical Llp (VPL) is 8 Year, 30 Days old Limited Liability Partnership 13 January 2017. Its registered office is in Dehradun, Uttarakhand, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2022 (FY 2021-2022). It's Total Obligation of Contribution is Rs 0.50 M as per MCA.
Company Details
-
Location
Dehradun, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAI-2623
-
Incorporation Date
13 Jan 2017
-
Date of Accounts and Solvency Statement
31 Mar 2022
-
ROC Code
Roc-Uttarakhand
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Vellmine Pharmaceutical Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bipin Kumar
|
Designated Partner | 13-Jan-2017 | Current |
|
Saurabh Kumar
|
Designated Partner | 01-Oct-2019 | Current |
Financial Performance of Vellmine Pharmaceutical Llp.
Vellmine Pharmaceutical Llp, for the financial year ended 2020, experienced significant growth in revenue, with a 35.93% increase. The company also saw a substantial fall in profitability, with a 55.14% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vellmine Pharmaceutical Llp?
Unlock access to Vellmine Pharmaceutical Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Giowill Pharma Private LimitedBipin Kumar is a mutual person
-
Vellmine Lifescience Private Limited
Bipin Kumar is a mutual person
Charges (Loans)
₹5.00 M
₹3.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Nov 2022 | Hdfc Bank Limited | ₹5.00 M | Open |
| 14 Aug 2020 | Bank Of Baroda | ₹3.00 M | Satisfied |
How Many Employees Work at Vellmine Pharmaceutical Llp?
Unlock and access historical data on people associated with Vellmine Pharmaceutical Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vellmine Pharmaceutical Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vellmine Pharmaceutical Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.